Palvella Therapeutics Up Over 34%, on Track for Highest Close Since March 2023 -- Data Talk

Dow Jones
Feb 24

Palvella Therapeutics, Inc. (PVLA) is currently at $117.90, up $30.06 or 34.22%

 

--Would be highest close since March 28, 2023, when it closed at $118.40

--On pace for largest percent increase since July 24, 2024, when it rose 88.6%

--Currently up four consecutive days; up 48.12% over this period

--Longest winning streak since Dec. 8, 2025, when it rose for four straight trading days

--Best four day stretch since the four days ending July 29, 2024, when it rose 104.89%

--Up 53.74% month-to-date; on pace for best month since July 2025, when it rose 62.29%

--Up 12.64% year-to-date

--Down 84.4% from its all-time closing high of $756.00 on Feb. 13, 2018

--Up 510.56% from 52 weeks ago (Feb. 25, 2025), when it closed at $19.31

--Would be a new 52-week closing high

--Up 527.13% from its 52-week closing low of $18.80 on Feb. 26, 2025

--Traded as high as $127.69; highest intraday level since Feb. 21, 2023, when it hit $129.79

--Up 45.37% at today's intraday high; largest intraday percent increase since July 24, 2024, when it rose as much as 118.67%

 

All data as of 10:30:46 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

February 24, 2026 10:33 ET (15:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10